Topical Corticosteroids for Infectious Keratitis Before Culture-Proven Diagnosis

References

• Ogawa GSH, Hyndiuk RA. Clinical disease (bacterial keratitis and conjunctivitis). In: Smolin G, Thoft RA, editors. The Cornea. 3rd ed. Boston: Little, Brown, and Company; 1994:130–133.
   Google Scholar
• Dahlgren MA, Lingappan A, Wilhelmus KR. The clinical diagnosis of microbial keratitis. Am J Ophthalmol. 2007;143(6):940–944. doi:10.1016/j.ajo.2007.02.030
   PubMed Web of Science ®Google Scholar
• Austin A, Lietman T, Rose-Nussbaumer J. Update on the management of infectious keratitis. Ophthalmology. 2017;124(11):1678–1689. doi:10.1016/j.ophtha.2017.05.012
   PubMed Web of Science ®Google Scholar
• McDonnell PJ, Nobe J, Gauderman WJ, et al. Community care of corneal ulcers. Am J Ophthalmol. 1992;114(5):531–538. doi:10.1016/S0002-9394(14)74479-4
   PubMed Web of Science ®Google Scholar
• Rodman RC, Spisak S, Sugar A, et al. The utility of culturing corneal ulcers in a tertiary referral center versus a general ophthalmology clinic. Ophthalmology. 1997;104(11):1897–1901. doi:10.1016/S0161-6420(97)30010-4
   Web of Science ®Google Scholar
• Lin A, Rhee MK, Akpek E, et al. Bacterial keratitis preferred practice pattern®. Ophthalmology. 2019;126(1):P1–P55.
   Web of Science ®Google Scholar
• Stern GA, Buttross M. Use of corticosteroids in combination with antimicrobial drugs in the treatment of infectious corneal disease. Ophthalmology. 1991;98(6):847–853. doi:10.1016/S0161-6420(91)32211-5
   PubMed Web of Science ®Google Scholar
• Hindman HB, Patel SB, Jun AS. Rationale for adjunctive topical corticosteroids in bacterial keratitis. Arch Ophthalmol. 2009;127(1):97–102. doi:10.1001/archophthalmol.2008.504
   PubMedGoogle Scholar
• Srinivasan M, Mascarenhas J, Rajaraman R, et al. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcer Trial (SCUT). Arch Ophthalmol. 2012;130(2):143–150. doi:10.1001/archophthalmol.2011.315
   PubMedGoogle Scholar
• Srinivasan M, Mascarenhas J, Rajaraman R, et al. The Steroids for Corneal Ulcer Trial (SCUT): secondary 12-month clinical outcome of a randomized controlled trial. Am J Ophthalmol. 2014;157(2):327–333. doi:10.1016/j.ajo.2013.09.025
   PubMed Web of Science ®Google Scholar
• Carmichael TR, Gelfand Y, Welsh NH. Topical steroids in the treatment of central and paracentral corneal ulcers. Br J Ophthalmol. 1990;74(9):528–531. doi:10.1136/bjo.74.9.528
   Web of Science ®Google Scholar
• Blair J, Hodge W, Al-Ghamdi S, et al. Comparison of antibiotic-only and antibiotic-steroid combined treatment in corneal ulcer patients: double-blinded randomized clinical trial. Can J Ophthalmol. 2011;46(1):40–45. doi:10.3129/i10-054
   PubMed Web of Science ®Google Scholar
• Palioura S, Henry CR, Amescua G, Alfonso EC. Role of steroids in the treatment of bacterial keratitis. Clin Ophthalmol. 2016;10:179–186. doi:10.2147/OPTH.S80411
   Google Scholar
• Jones DB. Corticosteroids for bacterial keratitis. Who gets them? JAMA Ophthalmol. 2013;131(2):233–234. doi:10.1001/jamaophthalmol.2013.1610
   Web of Science ®Google Scholar
• Wilhelmus KR. Indecision about corticosteroids for bacterial keratitis. An evidence-based update. Ophthalmology. 2002;109(5):835–844. doi:10.1016/S0161-6420(02)00963-6
   Web of Science ®Google Scholar
• Ni N, Srinivasan M, McLeod SD, et al. Use of adjunctive corticosteroids in bacterial keratitis. Curr Opin Ophthalmol. 2016;27(4):353–357. doi:10.1097/ICU.0000000000000273
   PubMed Web of Science ®Google Scholar
• Cohen EJ. The case against the use of steroids in the treatment of bacterial keratitis. Arch Ophthalmol. 2009;127(1):103–104. doi:10.1001/archophthalmol.2008.503
   PubMedGoogle Scholar
• Henry CR, Flynn HW, Miller D, Forster RK, Alfonso EC. Infectious keratitis progressing to endophthalmitis: a 15-year-study of microbiology, associated factors, and clinical outcomes. Ophthalmology. 2012;119(12):2443–2449. doi:10.1016/j.ophtha.2012.06.030
   PubMed Web of Science ®Google Scholar
• McClellan K, Howard K, Niederkorn JY, Alizadeb H. Effect of steroids on Acanthamoeba cysts and trophozoites. Invest Ophthalmol Vis Sci. 2001;42(12):2885–2893.
   Web of Science ®Google Scholar
• Park DH, Palay DA, Daya SM, Stulting RD, Krachmer JH, Holland EJ. The role of topical corticosteroids in the treatment of Acanthamoeba keratitis. Cornea. 1997;16(3):277–283. doi:10.1097/00003226-199705000-00004
   PubMed Web of Science ®Google Scholar
• Dart JK, Saw VPJ, Kilvington S. Acanthamoeba keratitis: diagnosis and treatment update 2009. Am J Ophthalmol. 2009;148(4):487–499. doi:10.1016/j.ajo.2009.06.009
   PubMed Web of Science ®Google Scholar
• D’Aversa G, Stern GA, Driebe WT Jr. Diagnosis and successful medical treatment of Acanthamoeba Keratitis. Arch Ophthalmol. 1995;113(9):1120–1123. doi:10.1001/archopht.1995.01100090046021
   Google Scholar
• Hirano K. Factors which affect the progression and severity of Acanthamoeba keratitis. Nippon Ganka Gakkai Zasshi. 2011;115(10):899–904.
   Google Scholar
• Tuli SS. Topical corticosteroids in the management of bacterial keratitis. Curr Ophthalmol Rep. 2013;1(4):190–193. doi:10.1007/s-40135-013-0026-0
   Google Scholar
• Marangon FB, Miller D, Alfonso EC. Impact of prior therapy on the recovery and frequency of corneal pathogens. Cornea. 2004;23(2):158–164. doi:10.1097/00003226-200403000-00009
   Web of Science ®Google Scholar
• Miedziak AI, Miller MR, Rapuano CJ, Libson PR, Cohen EJ. Risk factors in microbial keratitis leading to penetrating keratoplasty. Ophthalmology. 1999;106(6):1166–1171. doi:10.1016/S0161-6420(99)90250-6
   Web of Science ®Google Scholar
• Dalmon C, Porco TC, Lietman TM, et al. The clinical differentiation of bacterial and fungal keratitis: a photographic survey. Invest Ophthalmol Vis Sci. 2012;53(4):1787–1791. doi:10.1167/iovs.11-8478
   PubMed Web of Science ®Google Scholar
• O’Day DM. Corticosteroids: an unresolved debate. Ophthalmology. 1991;98(6):845–846. doi:10.1016/S0161-6420(91)32212-7
   Web of Science ®Google Scholar